| 3.35 -0.15 (-4.29%) | 10-06 09:55 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 1-year : | ||
| Resists | First : | Second : | ||
| Pivot price | ||||
| Supports | First : | Second : | ||
| MAs | MA(5) : | MA(20) : | ||
| MA(100) : | MA(250) : | |||
| MACD | MACD : | Signal : | ||
| %K %D | K(14,3) : | D(3) : | ||
| RSI | RSI(14): | |||
| 52-week | High : | Low : | ||
| If tomorrow: | Open lower | Open higher |
| High: | - | - |
| Low: | - | - |
| Close: | - | - |
Marpai, Inc. operates as a technology-driven healthcare payer, concentrating its efforts on the self-insured employer market within the United States and Israel. The firm provides a comprehensive suite of supplementary services, which includes managing patient care and individual cases, actuarial evaluations, administering health savings accounts, and implementing cost-saving measures. Additionally, Marpai innovates in artificial intelligence and healthcare technology. These advanced platforms process data to anticipate and preempt issues such as diagnostic inaccuracies, preventable hospitalizations, and administrative inefficiencies. Incorporated in 2021, the company's main office is situated in New York, New York.
Mon, 28 Sep 2026
Marpai Inc (OTC: MRAI) Share Price, MRAI Stock News, MRAI Share Price & Updates - kalkine.ca
Fri, 18 Sep 2026
Marpai Inc (MRAI) Key Financial Ratios – Valuation, Profitability & More - Value Research
Fri, 04 Sep 2026
Marpai Inc (MRAI) Peer Comparison – Compare with Others - Value Research
Thu, 13 Aug 2026
Marpai Reports Second Quarter 2026 Financial Results - PR Newswire
Thu, 13 Aug 2026
Calvin Steven Mitchell Discloses Investment at Marpai, Inc. with 9.3% Stake - TradingView
Wed, 29 Jul 2026
Marpai raises $12 million in private placement - Investing.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
OTC
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Plans
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | (%) |
| Held by Institutions | (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | |
| EPS Est Next Qtrly | |
| EPS Est This Year | |
| EPS Est Next Year | |
| Book Value (p.s.) | |
| Profit Margin | % |
| Operating Margin | % |
| Return on Assets (ttm) | % |
| Return on Equity (ttm) | % |
| Qtrly Rev. Growth | % |
| Gross Profit (p.s.) | |
| Sales Per Share | |
| EBITDA (p.s.) | |
| Qtrly Earnings Growth | % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | |
| PEG Ratio | |
| Price to Book value | |
| Price to Sales | |
| Price to Cash Flow |
| Dividend | |
| Forward Dividend | |
| Dividend Yield | 0% |
| Dividend Pay Date | |
| Ex-Dividend Date |
|
|
|
|
|
|
|
|
|